Berry blend may buy time after early water break
NCT ID NCT06788132
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether a daily capsule of cranberry, hibiscus, vitamin C, and lactobacillus could lengthen the time between a pregnant woman's waters breaking early (between 24 and 34 weeks) and delivery. 84 women were randomly assigned to receive either the supplement or a placebo for 10 days. The goal was to see if the supplement could safely delay birth and reduce complications for both mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cranberry extract, hibiscus extract, vitamin C, and lactobacillus
- What this could lead to
- If it works, this could offer a simple, natural way to delay delivery after waters break early, potentially reducing complications for mother and baby.
- What could go wrong
- This is a small, completed trial with only 84 participants. The results may not apply to all pregnant women, and supplements may not significantly extend the latency period.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
84 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients who agree to participate in the study. * Patients who sign the informed consent form. * Patients who can read and write. * Patients without alterations in the cognitive system. * Patients who had their delivery at the Maternal and Child Hospital. * Patients with admission criteria for conservative management in the pathology ward of the Hospital Escuela. * Patients with a single non-abnormal fetus. * Premature rupture of membranes with pregnancy of \>24.0 and \<34.0 weeks of gestation. Exclusion Criteria: * Patients who do not wish to participate in the study * Fetus with pulmonary anomalies, central nervous system and cardiopathies. * Patient with chorioamnionitis. * Premature rupture of membranes experienced within 14 days after amniocentesis or cervical cerclage placement. * Multiple gestation. * Delivery within 24 hours after admission. * Intrauterine fetal death at presentation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Fetal complications are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, 11101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.